IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma.
Megan MontoyaSara A CollinsPavlina ChuntovaTrishna S PatelTakahide NejoAkane YamamichiNoriyuki KasaharaHideho OkadaPublished in: bioRxiv : the preprint server for biology (2024)
expression of IRF8 may reduce immunosuppression and enhance antigen presentation, achieving improved tumor control.